Special attention must be taken for patients with hypokalaemia as this solution is potassium-free (see Precautions).
Reporting of suspected adverse reactions: Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the relevant national reporting system.
View ADR Reporting Link
Sign Out